Search details
1.
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours.
J Hepatol
; 80(3): 431-442, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-37972660
2.
The role of the caregiver in older patients with advanced prostate cancer: results from the ADHERE Prospective Study of the Meet-URO network.
Support Care Cancer
; 31(7): 425, 2023 Jun 26.
Article
in English
| MEDLINE | ID: mdl-37358628
3.
Pembrolizumab Plus Axitinib for Metastatic Papillary and Chromophobe Renal Cell Carcinoma: NEMESIA (Non Clear MEtaStatic Renal Cell Carcinoma Pembrolizumab Axitinib) Study, a Subgroup Analysis of I-RARE Observational Study (Meet-URO 23a).
Int J Mol Sci
; 24(2)2023 Jan 06.
Article
in English
| MEDLINE | ID: mdl-36674615
4.
Adherence to Oral Treatments in Older Patients with Advanced Prostate Cancer, the ADHERE Study: A Prospective Trial of the Meet-URO Network.
Oncologist
; 27(12): e949-e956, 2022 Dec 09.
Article
in English
| MEDLINE | ID: mdl-35920559
5.
Treatments after progression to first-line FOLFOXIRI and bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies by GONO.
Br J Cancer
; 124(1): 183-190, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33024268
6.
Safety and Efficacy of Tivozanib in First-Line mRCC: A Multicenter Compassionate-Use Study (Meet-Uro 16).
Oncology
; 99(12): 747-755, 2021.
Article
in English
| MEDLINE | ID: mdl-34583356
7.
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues.
Gastroenterology
; 155(2): 479-489.e7, 2018 08.
Article
in English
| MEDLINE | ID: mdl-29655834
8.
Prognostic evaluation in palliative care: final results from a prospective cohort study.
Support Care Cancer
; 27(6): 2095-2102, 2019 Jun.
Article
in English
| MEDLINE | ID: mdl-30229339
9.
Sarcopenia in gastric cancer: when the loss costs too much.
Gastric Cancer
; 20(4): 563-572, 2017 Jul.
Article
in English
| MEDLINE | ID: mdl-28477106
10.
Prognostic role of KRAS, NRAS, BRAF and PIK3CA mutations in advanced colorectal cancer.
Future Oncol
; 11(4): 629-40, 2015.
Article
in English
| MEDLINE | ID: mdl-25686118
11.
Impact of visceral metastases on outcome to abiraterone after docetaxel in castration-resistant prostate cancer patients.
Future Oncol
; 11(21): 2881-91, 2015.
Article
in English
| MEDLINE | ID: mdl-26436290
12.
Risk of unplanned visits for colorectal cancer outpatients receiving chemotherapy: a case-crossover study.
Support Care Cancer
; 22(9): 2527-33, 2014 Sep.
Article
in English
| MEDLINE | ID: mdl-24728616
13.
Assessing the effectiveness and safety of lenvatinib and everolimus in advanced renal cell carcinoma: insights from the RELIEVE study's analysis of heavily pretreated patients.
Ther Adv Urol
; 16: 17562872241244574, 2024.
Article
in English
| MEDLINE | ID: mdl-38638242
14.
Instrumental activities of daily living in older patients with metastatic prostate cancer: results from the meet-URO network ADHERE prospective study.
Sci Rep
; 14(1): 4949, 2024 02 28.
Article
in English
| MEDLINE | ID: mdl-38418470
15.
Clinical Outcomes and Prognostic Factors in Patients With Penile Carcinoma: A Sub-Analysis From Meet-URO 23 (I-RARE) Registry Study.
Clin Genitourin Cancer
; 22(3): 102074, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38616147
16.
Unveiling the Potential of Venn Diagrams as a Helpful Tool for Clinical Reasoning: An Illustrative Case-based Discussion.
Curr Probl Diagn Radiol
; 52(6): 478-481, 2023.
Article
in English
| MEDLINE | ID: mdl-37438231
17.
Addition of Niraparib to Best Supportive Care as Maintenance Treatment in Patients with Advanced Urothelial Carcinoma Whose Disease Did Not Progress After First-line Platinum-based Chemotherapy: The Meet-URO12 Randomized Phase 2 Trial.
Eur Urol
; 83(1): 82-89, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36216658
18.
Impact of influenza vaccination on survival of patients with advanced cancer receiving immune checkpoint inhibitors (INVIDIa-2): final results of the multicentre, prospective, observational study.
EClinicalMedicine
; 61: 102044, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-37434748
19.
Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis.
iScience
; 26(11): 107970, 2023 Nov 17.
Article
in English
| MEDLINE | ID: mdl-37860695
20.
Rare and Insidious Toxicities from New Combination Therapies in Metastatic Renal Cell Cancer: Lessons Learned from Real-Practice.
Curr Oncol
; 29(10): 6776-6786, 2022 09 22.
Article
in English
| MEDLINE | ID: mdl-36290810